Menu

Largest King Penguin Colony Population Has Declined Drastically

Compared to 500,000 breeding pairs in the 1980s, only 60,000 penguin pairs now remain.

Jul 31, 2018
Sukanya Charuchandra

ABOVE: ©ISTOCK, SERENGETI130

The second-largest penguin population in the world has lost 88 percent of its members, researchers reported last week (July 25) in Antarctic Science. The penguins live on Ile aux Cochons (Pig Island), which lies in the southern Indian Ocean between Africa and Antartica.  

The decline “is completely unexpected, and particularly significant since this colony represented nearly one third of the king penguins in the world,” coauthor Henri Weimerskirch, an ecologist at the Centre for Biological Studies in France, tells Agence France-Presse.

Weimerskirch and his colleagues used aerial and satellite imagery to analyze changes in the colony size over the last five decades. Since the 1980s, the world’s largest king penguin population has shrunk from 500,000 breeding pairs to only 60,000 breeding pairs. 

According to CNN, the decline appears to have begun in the late 1990s, around the same time as an El Niño event, which drove fish and other creatures south, away from the king penguins. The penguins depend on the fish and other critters for sustenance. An earlier study by the same group found the archipelago to which Pig Island belongs may be uninhabitable for king penguins by the end of the century, threatening the existence of over 70 percent of the species.

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN Ltd are pleased to announce the commercial licensing of CRISPR-Cas9 gene-editing technology from Broad Institute of MIT and Harvard in the USA, to develop human cell disease models to support preclinical metabolic disease therapeutic programmes.